These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 347110

  • 1. High- and low-potency neuroleptics in elderly psychiatric patients.
    Branchey MH, Lee JH, Amin R, Simpson GM.
    JAMA; 1978 May 05; 239(18):1860-2. PubMed ID: 347110
    [Abstract] [Full Text] [Related]

  • 2. Drug treatment in newly admitted schizophrenic patients.
    Clark ML, Huber WK, Charalampous KD, Serafetinides EA, Trousdale W, Colmore JP.
    Arch Gen Psychiatry; 1971 Nov 05; 25(5):404-9. PubMed ID: 4943915
    [No Abstract] [Full Text] [Related]

  • 3. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM, Erickson WD, Yellin AM, Hopwood JH, Greenberg LM.
    Am J Psychiatry; 1984 Mar 05; 141(3):440-2. PubMed ID: 6367494
    [Abstract] [Full Text] [Related]

  • 4. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS, Murungi JH.
    Ann Pharmacother; 2005 Jun 05; 39(6):1131-5. PubMed ID: 15840734
    [Abstract] [Full Text] [Related]

  • 5. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC, Mattsson NB.
    Dis Nerv Syst; 1968 May 05; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract] [Full Text] [Related]

  • 6. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 May 05; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 7. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY, Sachar EJ, Frantz AG.
    Biol Psychiatry; 1975 Feb 05; 10(1):53-7. PubMed ID: 1120175
    [Abstract] [Full Text] [Related]

  • 8. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA, Laughren T, Chisholm E, Williams BW.
    Arch Gen Psychiatry; 1982 Sep 05; 39(9):998-1000. PubMed ID: 6126172
    [Abstract] [Full Text] [Related]

  • 9. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW, Kulhanek F.
    Arzneimittelforschung; 1978 Sep 05; 28(9):1489-91. PubMed ID: 383096
    [Abstract] [Full Text] [Related]

  • 10. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
    Altamura AC, Mauri MC, Girardi T, Panetta B.
    Int J Clin Pharmacol Res; 1990 Sep 05; 10(4):223-8. PubMed ID: 2079381
    [Abstract] [Full Text] [Related]

  • 11. Drug-induced dystonia.
    Swett C.
    Am J Psychiatry; 1975 May 05; 132(5):532-4. PubMed ID: 1119613
    [Abstract] [Full Text] [Related]

  • 12. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G, Annable L, Ross-Chouinard A.
    Am J Psychiatry; 1982 Mar 05; 139(3):312-8. PubMed ID: 6120655
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
    Barcia D, Pozo P, Ruiz ME, Forcadell F, Morcillo L, Soria JM, Carrasco E.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987 Mar 05; 15(1):25-8. PubMed ID: 3577874
    [No Abstract] [Full Text] [Related]

  • 14. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B.
    Int Clin Psychopharmacol; 1986 Jul 05; 1 Suppl 1():15-23. PubMed ID: 3549878
    [Abstract] [Full Text] [Related]

  • 15. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine.
    Crowley TJ, Hydinger-Macdonald M.
    Arch Gen Psychiatry; 1981 Jun 05; 38(6):668-75. PubMed ID: 7247630
    [Abstract] [Full Text] [Related]

  • 16. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG, Todd N, Livingston M, Eccleston D, Watt JA, Tait D, Crocket G, Mitchell MJ, Huitfeldt B.
    Acta Psychiatr Scand; 1988 Jul 05; 78(1):49-56. PubMed ID: 2972165
    [Abstract] [Full Text] [Related]

  • 17. Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
    Koreen AR, Lieberman J, Alvir J, Chakos M, Loebel A, Cooper T, Kane J.
    Am J Psychiatry; 1994 Jan 05; 151(1):35-9. PubMed ID: 8267132
    [Abstract] [Full Text] [Related]

  • 18. Are antipsychotic drugs interchangeable?
    Gardos G.
    J Nerv Ment Dis; 1974 Nov 05; 159(5):343-8. PubMed ID: 4612111
    [No Abstract] [Full Text] [Related]

  • 19. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
    Martin IC.
    Acta Psychiatr Scand; 1975 Feb 05; 51(2):110-8. PubMed ID: 235189
    [Abstract] [Full Text] [Related]

  • 20. Dissimilar dosing with high-potency and low-potency neuroleptics.
    Baldessarini RJ, Katz B, Cotton P.
    Am J Psychiatry; 1984 Jun 05; 141(6):748-52. PubMed ID: 6145357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.